Search Results - "Rodríguez‐Frias, F."

Linoleic acid-derived oxylipins and isoprostanes plasma levels are influenced by 1,25-Dihydroxyvitamin D levels in middle-aged sedentary adults: The FIT-AGEING study by Vázquez-Lorente, Héctor, Jurado-Fasoli, Lucas, Kohler, Isabelle, Di, Xinyu, Yang, Wei, Osuna-Prieto, Francisco J., Asadov, Sardor, Frias-Rodríguez, José F., Castillo-Garzón, Manuel J., Amaro-Gahete, Francisco J.

“…Vitamin D – concretely its active form 1,25-dihydroxyvitamin D (1,25(OH)2D) – maintains several physiological processes. Oxylipins are oxidized lipids derived…”
Get full text

Serum hepatitis B core-related antigen is more accurate than hepatitis B surface antigen to identify inactive carriers, regardless of hepatitis B virus genotype by Riveiro-Barciela, M., Bes, M., Rodríguez-Frías, F., Tabernero, D., Ruiz, A., Casillas, R., Vidal-González, J., Homs, M., Nieto, L., Sauleda, S., Esteban, R., Buti, M.

“…To investigate whether hepatitis B surface antigen (HBsAg) and hepatitis B core-related antigen (HBcrAg) levels are useful to identify inactive carriers among…”
Get full text

Prevalence and distribution of hepatitis C virus genotypes in Spain during the 2000‐2015 period (the GEHEP 005 study) by Aguilera, A., Navarro, D., Rodríguez‐Frias, F., Viciana, I., Martínez‐Sapiña, A. M., Rodríguez, M. J., Martró, E., Lozano, M. C., Coletta, E., Cardeñoso, L., Suárez, A., Trigo, M., Rodríguez‐Granjer, J., Montiel, N., Iglesia, A., Alados, J. C., Vegas, C., Bernal, S., Fernández‐Cuenca, F., Pena, M. J., Reina, G., García‐Bujalance, S., Echevarria, M. J., Benítez, L., Pérez‐Castro, S., Ocete, D., García‐Arata, I., Guerrero, C., Rodríguez‐Iglesias, M., Casas, P., García, F.

“…Summary We report the largest study on the prevalence and distribution of HCV genotypes in Spain (2000‐2015), and we relate them with clinical, epidemiological…”
Get full text

Clinical outcome of acute and chronic hepatitis delta over time: a long-term follow-up study by Buti, M., Homs, M., Rodriguez-Frias, F., Funalleras, G., Jardí, R., Sauleda, S., Tabernero, D., Schaper, M., Esteban, R.

“…Long‐term changes in the frequency and outcome of hepatitis delta virus (HDV) infection have seldom been analysed. This retrospective, longitudinal study…”
Get full text

Identification of sapovirus GV.2, astrovirus VA3 and novel anelloviruses in serum from patients with acute hepatitis of unknown aetiology by Gonzales-Gustavson, Eloy, Timoneda, N, Fernandez-Cassi, X, Caballero, A, Abril, J F, Buti, M, Rodriguez-Frias, F, Girones, R

“…Hepatitis is a general term meaning inflammation of the liver, which can be caused by a variety of viruses. However, a substantial number of cases remain with…”
Get full text

P0624 : Acute viral hepatitis: Epidemiological change during the last 25 years in Spain by Riveiro-Barciela, M, Mena, E, Romero, S, Ventura-Cots, M, Llaneras, J, Rodríguez-Frias, F, Esteban, R, Buti, M

Get full text

HIV, HEV and cirrhosis: evidence of a possible link from eastern Spain by Jardi, R, Crespo, M, Homs, M, Eynde, E, Girones, R, Rodriguez‐Manzano, J, Caballero, A, Buti, M, Esteban, R, Rodriguez‐Frias, F

“…Objectives The aim of the study was to assess the seroprevalence of hepatitis E virus (HEV) infection in an HIV‐infected population, as determined by HEV…”
Get full text

Hepatitis B virus quasispecies evolution after liver transplantation in patients under long-term lamivudine prophylaxis with or without hepatitis B immune globulin by Buti, M., Tabernero, D., Mas, A., Homs, M., Prieto, M., Rodríguez-Frías, F., Casafont, F., Casillas, R., González, A., Miras, M., Herrero, J.I., Castells, L., Esteban, R.

“…Aims To investigate an optimal long‐term prophylactic strategy for prevention of hepatitis B virus (HBV) recurrence after liver transplantation, we conducted a…”
Get full text

Early predictors of antiviral treatment response in liver transplant recipients with recurrent hepatitis C genotype 1 by Campos-Varela, I., Esteban, J. I., Bes, M., Caralt, M., Allende, H., Rodríguez-Frías, F., Salcedo, M. T., Sauleda, S., Charco, R., Guardia, J., Esteban, R., Castells, L.

“…Summary The success of current antiviral treatment for hepatitis C virus (HCV) recurrence in liver transplant (LT) recipients remains limited. We aimed at…”
Get full text

Viral genotype and baseline load predict the response to adefovir treatment in lamivudine-resistant chronic hepatitis B patients by Buti, M, Elefsiniotis, I, Jardi, R, Vargas, V, Rodriguez-Frias, F, Schapper, M, Bonovas, S, Esteban, R

“…Background/Aims To determine the factors associated with virological response (VR), HBeAg loss or the emergence of adefovir (ADV)-related mutations in…”
Get full text

P657 IN VIVO MUTAGENIC EFFECT OF RIBAVIRIN ON SUBTYPE 3F HEV QUASISPECIES ISOLATED FROM A PATIENT INFECTED FROM PORK MEAT by Casillas, R, Rodríguez-Frias, F, Mínguez, B, Riveiro, M, Gregori, J, Garcia-Cehic, D, Tabernero, D, Homs, M, Blasi, M, Caballero, A, Nieto, L, Hundesa, A, Girones, R, Buti, M, Quer, J

Get full text

Application of a diagnostic algorithm for the rare deficient variant Mmalton of alpha-1-antitrypsin deficiency: a new approach by Belmonte, Irene, Barrecheguren, Miriam, López-Martínez, Rosa M, Esquinas, Cristina, Rodríguez, Esther, Miravitlles, Marc, Rodríguez-Frías, Francisco

“…Alpha-1-antitrypsin deficiency (AATD) is associated with a high risk for the development of early-onset emphysema and liver disease. A large majority of…”
Get full text

P1110 HIGH-RESOLUTION HCV SUBTYPING USING MASSIVE SEQUENCING AND PHYLOGENY, OPTIMAL ALTERNATIVE TO CURRENT METHODS by Quer, J, Gregori, J, Rodríguez-Frias, F, Buti, M, Madejon, A, Perez del Pulgar, S, Garcia-Cehic, D, Casillas, R, Blasi, M, Homs, M, Tabernero, D, Alvarez-Tejado, M, Muñoz, J.M, Cubero, M, Caballero, A, Esteban, R, Guardia, J, Garcia-Samaniego, J, Forns, X, Esteban, J.I

Get full text

Main mutations in the hepatitis B virus basic core promoter (A1762T/G1764A) before HBeAg loss are markers that identify patients who will require long‐term treatment by Tabernero, D., Sánchez, M. J., Homs, M., Rodríguez‐Frías, F., Jardí, R., Schaper, M., Esteban, R., Buti, M.

“…Aliment Pharmacol Ther 2010; 32: 97–104 Summary Background  Some patients continue to have detectable HBV‐DNA levels with liver disease progression after…”
Get full text

Hepatitis B virus polymerase variants associated with entecavir drug resistance in treatment-naive patients by Jardi, R., Rodriguez-Frias, F., Schaper, M., Ruiz, G., Elefsiniotis, I., Esteban, R., Buti, M.

“…It has been suggested that lamivudine therapy can preselect for hepatitis B virus (HBV) variants associated with resistance to entecavir (ETV) treatment. The…”
Get full text

IL28B genetic variation and hepatitis C virus-specific CD4+ T-cell responses in anti-HCV-positive blood donors by Bes, M., Sauleda, S., Campos-Varela, I., Rodriguez-Frias, F., Casamitjana, N., Homs, M., Piron, M., Quer, J., Tabernero, D., Guardia, J., Puig, L., Esteban, J. I.

“…Epidemiological, viral and host factors are associated with the outcome of hepatitis C virus (HCV) infection, and strong host immune responses against HCV…”
Get full text

1257 IS LIVER CIRRHOSIS ASSOCIATED WITH INCREASED SUSCEPTIBILITY TO INFECTION BY HEPATITIS E VIRUS? by Jardí, R, Tabernero, D, Horns, M, Rodríguez-Frias, F, Castells, L, Campos-Varela, I, Caballero, A, Cantarell, M.C, Girones, R, Esteban, R, Buti, M

Get full text

Plasma SHBG Levels as an Early Predictor of Response to Bariatric Surgery by Gabriel-Medina, P., Ferrer-Costa, R., Rodriguez-Frias, F., Comas, M., Vilallonga, R., Ciudin, A., Selva, D. M.

“…Background Obesity is a growing global health problem, and currently, bariatric surgery (BS) is the best solution in terms of sustained total weight loss…”
Get full text

Hepatitis B virus genotypes and G1896A precore mutation in 486 Spanish patients with acute and chronic HBV infection by Rodriguez-Frias, F., Jardi, R., Buti, M., Schaper, M., Hermosilla, E., Valdes, A., Allende, H., Martell, M., Esteban, R., Guardia, J.

“…This study aims to determine the prevalence of hepatitis B virus (HBV) genotypes (A–F) and their association with the G1896A precore mutation in 486 patients…”
Get full text

Reliable resolution of ambiguous hepatitis C virus genotype 1 results with the Abbott HCV Genotype Plus RUO assay by Saludes, V., Antuori, A., Reinhardt, B., Viciana, I., Clavijo, E., Schreiber, L., Tenenbaum, M., Rodriguez-Frias, F., Quer, J., Matas, L., Martró, E.

“…Accurate subtyping of hepatitis C virus genotype 1 (HCV-1) remains clinically and epidemiologically relevant. The Abbott HCV Genotype Plus RUO (GT Plus )…”
Get full text